drugset / Trial / NCT05792774

Phrenic Nerve Infiltration in Fibromyalgia

NCT05792774 ↗

Phase 4 Completed 60 enrolled University of Seville
RandomizedParallel-groupDouble-blindTreatment

Summary

It is known that nociceptive afferences in visceral pain and visceral disorders increase sensitization in subjects suffering from fibromyalgia. These patients use to present visceral comorbidities. Those comorbidities include that of peridiaphragmatic organs, which are supplied by the phrenic nerve among other innervations. It is known that peridiaphragmatic organs trigger referred pain in the neck area, via the phrenic nerves. So, the phrenic nociceptive afferences can be contributing to enhance the state of sensitization in fibromyalgia. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization in subjects suffering fibromyalgia, by means of a randomized controlled trial.

Timeline

Start
2023-04-03
Primary completion
2024-02-19
Completion
2024-02-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Bupivacaine Other / unclassified 3 ml Other

Indications